Insulet (PODD) EPS (Basic) (2010 - 2026)

Insulet has reported EPS (Basic) for 17 years, with the latest figure at $1.3 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) rose 160.0% year-over-year to $1.3; the trailing twelve-month figure through Mar 2026 stood at $4.3 (down 25.09% YoY), and the FY2025 full-year result was $3.51, down 41.21% from the prior year.
• EPS (Basic) for Q1 2026 stood at $1.3, down from $1.44 in the prior quarter.
• The five-year high for EPS (Basic) was $2.69 in Q2 2024, with the low at -$0.5 in Q2 2022.
• Historically, EPS (Basic) has averaged $0.81 across 5 years, with a median of $0.74 in 2023.
• Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 144.44% — and 2023, when it soared 1025.0%.
• Insulet's EPS (Basic) stood at $0.25 in 2022, then surged by 492.0% to $1.48 in 2023, then decreased by 2.7% to $1.44 in 2024, then advanced by 0.0% to $1.44 in 2025, then slipped by 9.72% to $1.3 in 2026.
• The last three EPS (Basic) figures came in at $1.3 (Q1 2026), $1.44 (Q4 2025), and $1.24 (Q3 2025), per Business Quant data.